European Journal of Preventive Cardiology
The Role of Lipoprotein(a) in Predicting Coronary Artery Disease Among Ageing Endurance Athletes and Healthy Controls
Cohort study of 558 peopleLipoprotein
Papers on elevated Lp
133 papers37 new in 30 days
Saturday, October 18
Wednesday, September 10
Turk Kardiyoloji Dernegi Arsivi
Association of Lipoprotein(a) with Coronary Artery Calcification and Bone Mineral Density in Elderly Individuals
Cohort study of 310 peopleCoronary artery calcification
Friday, June 13
ADA Scientific Sessions 2025 Abstract
Association of Ethnicity and Diabetes with Elevated Lipoprotein(a) Levels in a Cross-Sectional Study of Adults in Kuwait
Cross-sectional study of 2,083 peopleType 2 diabetes
Monday, March 31
Reviews in Cardiovascular Medicine
The Association between Lipoprotein(a) and Coronary Artery Calcification in Elderly Patients with Diabetes: A Cross-Sectional Study
Cross-sectional study of 486 peopleLipoprotein
Monday, December 2
Diabetes, Metabolic Syndrome and Obesity
Lipoprotein(a) is Associated with Sarcopenia in Patients with Type 2 Diabetes: A cross-Sectional Study
Cross-sectional study of 426 peopleLipoprotein
Saturday, August 31
The Journal of International Medical Research
Elderly patients with very high plasma lipoprotein(a) concentrations and few cardiovascular consequences: a case series
Case series of 16 peopleCardiovascular disease
Wednesday, November 8
Nature Reviews Cardiology
Lipoprotein(a), platelet function and cardiovascular disease
ReviewMechanisms
Monday, September 11
Research and Practice in Thrombosis and Haemostasis
Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort
Study in peoplePopulations
Tuesday, December 28
Reviews in Cardiovascular Medicine
Relationship between Lipoprotein(a) and cardiovascular risk factors-data from 4602 participants of the ELITE study
Cross-sectional study of 4,602 peoplePopulations
Sunday, June 23
Friday, December 2
Sunday, October 1
Nutrition, Metabolism, and Cardiovascular Diseases
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)
Randomized trial in 36 peopleInterventions